D. Angelini et al., IMMUNOLOGICAL DISTURBANCES AND LEVELS OF PARATHYROID-HORMONE IN UREMIC PATIENTS IN REPLACEMENT DIALYSIS THERAPY, Clinical nephrology, 42(4), 1994, pp. 246-250
We studied the changes in cellular immunity in patients in replacement
dialysis therapy (RDT) and examined the relationship between T-lympho
cyte function and plasma levels of parathyroid hormone (PTH). In a pre
liminary study we found that increased plasma levels of PTH were assoc
iated with a decrease of T-lymphocytes and CD4, an increase in CD8 and
a reduction in the ratio of CD4 to CD8. In the present study we exami
ned the realtionship between plasma levels of PTH, interleukin 2 recep
tors (IL-2R) and soluble human CD8 (S-CD8). We studied 54 patients div
ided into two groups: 26 patients with normal levels of PTH and 28 pat
ients with increased levels of PTH. We found a significant reduction i
n total T-lymphocytes in both groups as compared to controls, with an
inverse correlation between total T-lymphocytes and plasma PTH in the
second group (R = -0.52). There was an increase in IL-2R in the group
II as compared to the controls and also in the total population of ure
mic patients with a linear correlation between levels of IL-2R and PTH
(R = 0.6). The levels of S-CD8 showed a significant increase in both
groups with a linear correlation between levels of SC-D8 and PTH (R =
0.63). No specific differences were seen between patients treated with
and without 1,25-dihydroxyvitamin D-3 The elevated levels of PTH affe
ct the lymphocyte function and are associated with change in cellular
immunity with reduction in total number of T cells, and increases in l
evels of CD8, S-CD8 and IL-2R.